News & Events
29 June 2024
PREFERABLE at the MASCC Annual Meeting
We are delighted to announce the presentation of final results of the PREFERABLE project during a workshop, at the MASCC congress in Lille on June 29th 2024!
13 March 2024
11th Consortium Meeting in Stockholm
During our 11th consortium meeting, exciting results from the cost-effectiveness and biomarker analyses were presented. Also, the consortium worked together to formulate our recommendations for relevant stakeholders.
8 January 2024
Following the San Antonio Breast Cancer Symposium, the ASCO post has written a nice article on the results of the Preferable project: Patients With Advanced Breast Cancer May Gain Multiple Benefits From Exercise as Part of Palliative Care

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.